Coronavirus: European Commission approves Pfizer vaccine



[ad_1]

Most of the content in the portfolio is available for free, as is this article.

However, the situation in the media market is constantly changing: if you want to support quality business journalism and want to be part of the Portfolio community, subscribe to Portfolio Signature articles. Know more

Mamer told a press conference that this is the fourth contract that the EU commission is concluding with pharmaceutical companies to procure a coronavirus vaccine.

The agreement will initially allow all EU member states to purchase 200 million doses of vaccine, as well as the possibility to request an additional 100 million doses.

The vaccine, developed by the two companies, is the most promising coronavirus vaccine ever produced, so the European Commission is working to distribute it in Europe as soon as it becomes available, he added.

Pfizer’s pre-open share price rose 0.5 percent, while it fell 1.3 percent this year.

Cover image: Spencer Platt / Getty Images



[ad_2]